·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ´ëÇѺ´¿øÇùȸ ȨÆäÀÌÁö Àü¸é°³Æí ±â»çÀÔ·Â : 13.12.16 15:17:42 0 °¡ ÇÃÄ£Ãß°¡ º´¿ø ¼ºñ½º°È¡¤´ë±¹¹Î À̹ÌÁö °³¼± ´ëÇѺ´¿øÇùȸ(http://www.kha.or.kr)°¡ ȸ¿øº´¿ø ¼ºñ½º°È¿Í ´ë±¹¹Î À̹ÌÁö °³¼±À» À§ÇØ È¨ÆäÀÌÁö¸¦ Àü¸é °³ÆíÇØ 16ÀÏ Á¤½Ä ¿ÀÇÂÇß´Ù. »õ·Ó°Ô ¼±º¸ÀÎ À̹ø ȨÆäÀÌÁö´Â ÀÌÀüº¸´Ù µðÀÚÀΰú ±â´ÉÀ» °³¼±½ÃÄ×À¸¸ç, Áö½Ä¼ºñ½º ±¸Ãà ¹× ¿Â¶óÀÎ È«º¸°ü µîÀ» ±¸ÃàÇØ ÇùȸÀÇ À̹ÌÁö Á¦°í¸¦ À§ÇØ ³ë·ÂÇß´Ù. ½Å±Ô ÄÜÅÙÃ÷ ¿ª½Ã °ÈµÆ´Ù. Åë°è¼ºñ½º ½Ã½ºÅÛ ±¸ÃàÀ» ÅëÇØ ½É»çÆò°¡¿ø Åë°èÁ¤º¸ÀڷḦ Ȱ¿ë, º´¿ø°æ¿µ¿¡ ÇÊ¿äÇÑ Á¤º¸ÀڷḦ Àû½Ã¿¡ Á¦°øÇÏ°Ô µÆ´Ù. ½Ãµµº´¿øÈ¸ ȨÆäÀÌÁö¸¦ À̹ø »õ ȨÆäÀÌÁö °³Æí°ú ¸ÂÃç ±¸ÃàÇßÀ¸¸ç, »õ·Î¿î ȨÆäÀÌÁö¿¡ ½Ãµµº´¿øÈ¸ ¼Ò½Ä¶õ, ÃֽŠȸ¿øº´¿ø Á¤º¸Á¦°ø ¹× ȸ¿øº´¿ø °ü¸®, ÀÇ·á Åë°èÁ¤º¸ÀÚ·á Ȱ¿ë¼ºñ½º µî ´Ù¾çÇÑ ¼ºñ½º¸¦ Á¦°øÇÑ´Ù. ÁÖ¿ä °³Æí ³»¿ëÀº ¡ãÃֽŠƮ·»µå¸¦ ¹Ý¿µÇÑ ´ë¿ÜÀû À̹ÌÁöÁ¦°í ¡ãÁö½ÄÁ¤º¸ DBÈ ¡ã¿¬¼ö±³À° »çÀÌÆ® °³¼± ¡ãÀÇ·á Åë°è Á¤º¸ÀÚ·á Ȱ¿ë¼ºñ½º ¡ã½Ãµµº´¿øÈ¸ »çÀÌÆ® º°µµ ±¸Ãà ¡ãȸ¿øº´¿ø ¹× ´ë±¹¹Î ¼ºñ½º °È µîÀÌ´Ù. X AD Á¾¼Ò¼¼ °£Æí°è»ê GO À̺¥Æ®Âü¿© ¡æ ÀÌÇý°æ ±âÀÚ(hgrace7@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ´ëÇѺ´¿øÇùȸ ȨÆäÀÌÁö Àü¸é°³Æí URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ´ëÇѺ´¿øÇùȸ ȨÆäÀÌÁö Àü¸é°³Æí ±â»çÀÔ·Â : 13.12.16 15:17:42 0 °¡ ÇÃÄ£Ãß°¡ º´¿ø ¼ºñ½º°È¡¤´ë±¹¹Î À̹ÌÁö °³¼± ´ëÇѺ´¿øÇùȸ(http://www.kha.or.kr)°¡ ȸ¿øº´¿ø ¼ºñ½º°È¿Í ´ë±¹¹Î À̹ÌÁö °³¼±À» À§ÇØ È¨ÆäÀÌÁö¸¦ Àü¸é °³ÆíÇØ 16ÀÏ Á¤½Ä ¿ÀÇÂÇß´Ù. »õ·Ó°Ô ¼±º¸ÀÎ À̹ø ȨÆäÀÌÁö´Â ÀÌÀüº¸´Ù µðÀÚÀΰú ±â´ÉÀ» °³¼±½ÃÄ×À¸¸ç, Áö½Ä¼ºñ½º ±¸Ãà ¹× ¿Â¶óÀÎ È«º¸°ü µîÀ» ±¸ÃàÇØ ÇùȸÀÇ À̹ÌÁö Á¦°í¸¦ À§ÇØ ³ë·ÂÇß´Ù. ½Å±Ô ÄÜÅÙÃ÷ ¿ª½Ã °ÈµÆ´Ù. Åë°è¼ºñ½º ½Ã½ºÅÛ ±¸ÃàÀ» ÅëÇØ ½É»çÆò°¡¿ø Åë°èÁ¤º¸ÀڷḦ Ȱ¿ë, º´¿ø°æ¿µ¿¡ ÇÊ¿äÇÑ Á¤º¸ÀڷḦ Àû½Ã¿¡ Á¦°øÇÏ°Ô µÆ´Ù. ½Ãµµº´¿øÈ¸ ȨÆäÀÌÁö¸¦ À̹ø »õ ȨÆäÀÌÁö °³Æí°ú ¸ÂÃç ±¸ÃàÇßÀ¸¸ç, »õ·Î¿î ȨÆäÀÌÁö¿¡ ½Ãµµº´¿øÈ¸ ¼Ò½Ä¶õ, ÃֽŠȸ¿øº´¿ø Á¤º¸Á¦°ø ¹× ȸ¿øº´¿ø °ü¸®, ÀÇ·á Åë°èÁ¤º¸ÀÚ·á Ȱ¿ë¼ºñ½º µî ´Ù¾çÇÑ ¼ºñ½º¸¦ Á¦°øÇÑ´Ù. ÁÖ¿ä °³Æí ³»¿ëÀº ¡ãÃֽŠƮ·»µå¸¦ ¹Ý¿µÇÑ ´ë¿ÜÀû À̹ÌÁöÁ¦°í ¡ãÁö½ÄÁ¤º¸ DBÈ ¡ã¿¬¼ö±³À° »çÀÌÆ® °³¼± ¡ãÀÇ·á Åë°è Á¤º¸ÀÚ·á Ȱ¿ë¼ºñ½º ¡ã½Ãµµº´¿øÈ¸ »çÀÌÆ® º°µµ ±¸Ãà ¡ãȸ¿øº´¿ø ¹× ´ë±¹¹Î ¼ºñ½º °È µîÀÌ´Ù. X AD Á¾¼Ò¼¼ °£Æí°è»ê GO À̺¥Æ®Âü¿© ¡æ ÀÌÇý°æ ±âÀÚ(hgrace7@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ´ëÇѺ´¿øÇùȸ ȨÆäÀÌÁö Àü¸é°³Æí URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ´ëÇѺ´¿øÇùȸ ȨÆäÀÌÁö Àü¸é°³Æí ±â»çÀÔ·Â : 13.12.16 15:17:42 0 °¡ ÇÃÄ£Ãß°¡ º´¿ø ¼ºñ½º°È¡¤´ë±¹¹Î À̹ÌÁö °³¼± ´ëÇѺ´¿øÇùȸ(http://www.kha.or.kr)°¡ ȸ¿øº´¿ø ¼ºñ½º°È¿Í ´ë±¹¹Î À̹ÌÁö °³¼±À» À§ÇØ È¨ÆäÀÌÁö¸¦ Àü¸é °³ÆíÇØ 16ÀÏ Á¤½Ä ¿ÀÇÂÇß´Ù. »õ·Ó°Ô ¼±º¸ÀÎ À̹ø ȨÆäÀÌÁö´Â ÀÌÀüº¸´Ù µðÀÚÀΰú ±â´ÉÀ» °³¼±½ÃÄ×À¸¸ç, Áö½Ä¼ºñ½º ±¸Ãà ¹× ¿Â¶óÀÎ È«º¸°ü µîÀ» ±¸ÃàÇØ ÇùȸÀÇ À̹ÌÁö Á¦°í¸¦ À§ÇØ ³ë·ÂÇß´Ù. ½Å±Ô ÄÜÅÙÃ÷ ¿ª½Ã °ÈµÆ´Ù. Åë°è¼ºñ½º ½Ã½ºÅÛ ±¸ÃàÀ» ÅëÇØ ½É»çÆò°¡¿ø Åë°èÁ¤º¸ÀڷḦ Ȱ¿ë, º´¿ø°æ¿µ¿¡ ÇÊ¿äÇÑ Á¤º¸ÀڷḦ Àû½Ã¿¡ Á¦°øÇÏ°Ô µÆ´Ù. ½Ãµµº´¿øÈ¸ ȨÆäÀÌÁö¸¦ À̹ø »õ ȨÆäÀÌÁö °³Æí°ú ¸ÂÃç ±¸ÃàÇßÀ¸¸ç, »õ·Î¿î ȨÆäÀÌÁö¿¡ ½Ãµµº´¿øÈ¸ ¼Ò½Ä¶õ, ÃֽŠȸ¿øº´¿ø Á¤º¸Á¦°ø ¹× ȸ¿øº´¿ø °ü¸®, ÀÇ·á Åë°èÁ¤º¸ÀÚ·á Ȱ¿ë¼ºñ½º µî ´Ù¾çÇÑ ¼ºñ½º¸¦ Á¦°øÇÑ´Ù. ÁÖ¿ä °³Æí ³»¿ëÀº ¡ãÃֽŠƮ·»µå¸¦ ¹Ý¿µÇÑ ´ë¿ÜÀû À̹ÌÁöÁ¦°í ¡ãÁö½ÄÁ¤º¸ DBÈ ¡ã¿¬¼ö±³À° »çÀÌÆ® °³¼± ¡ãÀÇ·á Åë°è Á¤º¸ÀÚ·á Ȱ¿ë¼ºñ½º ¡ã½Ãµµº´¿øÈ¸ »çÀÌÆ® º°µµ ±¸Ãà ¡ãȸ¿øº´¿ø ¹× ´ë±¹¹Î ¼ºñ½º °È µîÀÌ´Ù. X AD Á¾¼Ò¼¼ °£Æí°è»ê GO À̺¥Æ®Âü¿© ¡æ ÀÌÇý°æ ±âÀÚ(hgrace7@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ´ëÇѺ´¿øÇùȸ ȨÆäÀÌÁö Àü¸é°³Æí URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö